Hybrid Molecules of Benzothiazole and Hydroxamic Acid as Dual-Acting Biofilm Inhibitors with Antibacterial Synergistic Effect against Pseudomonas aeruginosa Infections
Journal of Medicinal Chemistry · 27.03.2025 · 68 (6) · 6210-6232
DOI: 10.1021/acs.jmedchem.4c02517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 13.03.2025. Verfasst von Zhen-Meng Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Pharmacy, Institute for Advanced and Applied Chemical Synthesis, …. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Hydroxamic Acids, Anti-Bacterial Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The ubiquitous opportunistic pathogen Pseudomonas aeruginosa (P. aeruginosa) causes biofilm-associated drug-resistant infections that often lead to treatment failure. Targeting the bacterium's quorum sensing (QS) and iron homeostasis presents a promising strategy to combat biofilm formation. This study synthesized benzothiazole-conjugated hydroxamic acid derivatives as dual-acting biofilm inhibitors, and compound JH21 was identified as the hit compound with potent submicromolar biofilm inhibitory activity (IC50 = 0.4 μM). Further mechanistic studies demonstrated not only that the production of virulence was decreased through mainly inhibiting QS system but also that JH21 competed for iron with the high-affinity siderophore pyoverdine, inducing iron deficiency and inhibiting biofilm. Moreover, JH21 significantly enhanced the efficacy of tobramycin and ciprofloxacin by 200- and 1000-fold, respectively, in a mouse wound infection model. These results emphasized the feasibility of dual-acting biofilm inhibitors against resistant P. aeruginosa infections and the potential of JH21 as a novel antibacterial synergist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Pharmacy, Institute for Advanced and Applied Chemical Synthesis, College of Pharmacy, Jinan University, Guangzhou 510632, P. R. China.
- Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832003, P. R. China.
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z. M., Zhao, S. Y., Liu, W. Q., Wu, X., Tang, J., Li, Y. J., Hu, X. B., Zhou, Y. B., Dai, L. X., Huang, M. Y., Lan, P., Sun, P. H., Xu, J., Liu, J., & Zheng, J. X. (2025). Hybrid Molecules of Benzothiazole and Hydroxamic Acid as Dual-Acting Biofilm Inhibitors with Antibacterial Synergistic Effect against Pseudomonas aeruginosa Infections. Journal of Medicinal Chemistry, 68(6), 6210-6232. https://doi.org/10.1021/acs.jmedchem.4c02517
Vancouver
Zhang ZM, Zhao SY, Liu WQ, Wu X, Tang J, Li YJ, et al. Hybrid Molecules of Benzothiazole and Hydroxamic Acid as Dual-Acting Biofilm Inhibitors with Antibacterial Synergistic Effect against Pseudomonas aeruginosa Infections. Journal of Medicinal Chemistry. 2025;68(6):6210-6232. doi:10.1021/acs.jmedchem.4c02517
BibTeX
@article{Zhang2025,
author = {Zhang, Zhen-Meng and Zhao, Si-Yu and Liu, Wen-Qian and Wu, Xiao and Tang, Jie and Li, Yu-Jie and Hu, Xi-Bing and Zhou, Ying-Bo and Dai, Li-Xuan and Huang, Mei-Yan and Lan, Ping and Sun, Ping-Hua and Xu, Jun and Liu, Jun and Zheng, Jun-Xia},
title = {Hybrid Molecules of Benzothiazole and Hydroxamic Acid as Dual-Acting Biofilm Inhibitors with Antibacterial Synergistic Effect against Pseudomonas aeruginosa Infections},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {6},
pages = {6210--6232},
doi = {10.1021/acs.jmedchem.4c02517}
}
EUVIMED